Clinical features of axial undifferentiated spondyloarthritis (USpA) in China: HLA-B27 is more useful for classification than MRI of the sacroiliac joint

Scandinavian Journal of Rheumatology

Volumn 40, Issue 6, 2011, Pages 439-443

  Liao, Z ^a   Lin, Z ^a   Xu, M ^a   Hu, Z ^a   Li, T ^a   Wei, Q ^a   Cao, S ^a   Huang, J ^a   Pan, Y ^a   Wu, Y ^a   Gu, J ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HLA B27 ANTIGEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; AXIAL UNDIFFERENTIATED SPONDYLOARTHRITIS; CHINA; CLINICAL FEATURE; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SACROILIAC JOINT;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CHINA; FEMALE; HLA-B27 ANTIGEN; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SACROILIAC JOINT; SPONDYLARTHRITIS; YOUNG ADULT;

EID: 83455196146     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2011.585348     Document Type: Article

References (15)

1. Hanova P, Pavelka K, Holcatova I, Pikhart H. Incidence and prevalence of psoriatic arthritis, ankylosing spondylitis, and reactive arthritis in the first descriptive population-based study in the Czech Republic. Scand J Rheumatol 2010;39:310-17.
2. Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, et al. The European Spondyloarthropathy Study Group preliminary criteria for the classification of spondyloarthropathy. Arthritis Rheum 1991;34:1218-27.
3. Rudwaleit M, Haibel H, Baraliakos X, Listing J, Marker-Hermann E, Zeidler H, et al. The early disease stage in axial spondyloarthritis results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum 2009;60:717-27.
4. Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009;68;777-83.
5. Rudwaleit M, Jurik AG, Hermann KG, Landewé R, van der Heijde D, Baraliakos X, et al. Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group. Ann Rheum Dis 2009;68;1520-7.
6. Rudwaleit M, van der Heijde D, Khan MA, Braun J, Sieper J. How to diagnose axial spondyloarthropathies early. Ann Rheum Dis 2004;63:535-43. (Pubitemid 38530197)
7. Liao ZT, Gu JR, Huang F, Lin ZM, Zhao LK, Yu BY. Verification of Berlin algorithm for diagnosing undifferentiated spondyloarthropathy patients in Chinese population. Joint Bone Spine 2009;76:146-9.
8. Braun J, Bollow M, Remlinger G, Eggens U, Rudwaleit M, Distler A, et al. Prevalence of spondyloarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 1998;41:58-67. (Pubitemid 28041923)
9. Feldtkeller E, Khan MA, van der Heijer D, van der Linder S, Braun J. Age at disease onset and diagnosis delay in HLA-B27 negative vs positive patients with ankylosing spondylitis. Rheumatol Int 2003; 23:61-6. (Pubitemid 36384722)
10. Marzo-Ortega H, McGonagle D, O'Connor P, Hensor EMA, Bennett AN, Green MJ, et al. Baseline and 1-year magnetic resonance imaging of the sacroiliac joint and lumbar spine in very early inflammatory back pain. Relationship between symptoms, HLA-B27 and disease extent and persistence. Ann Rheum Dis 2009;68:1721-7.
11. Bennett AN, McGonagle D, O'Connor P, Hensor EM, Sivera F, Coates LC, et al. Severity of baseline magnetic resonance imagingevident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years. Arthritis Rheum 2008; 58:3413-18.
12. Rudwaleit M, Schwarzlose S, Hilgert ES, Listing J, Braun J, Sieper J. MRI in predicting a major clinical response to antitumour necrosis factor treatment in ankylosing spondylitis. Ann Rheum Dis 2008;67:1276-81.
13. Rudwaleit M, Landewé R, van der Heijde D, Listing J, Brandt J, Braun J. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis 2009;68;770-6.
14. Lambert RGW, Salonen D, Rahman P, Inman RD, Wong RL, Einstein SG, et al. Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis. Arthritis Rheum 2007;56:4005-14.
15. Jarrett SJ, Sivera F, Cawkwell LS, Marzo-Ortega H, McGonagle D, Hensor E, et al. MRI and clinical findings in patients with ankylosing spondylitis eligible for anti-tumour necrosis factor therapy after a short course of etoricoxib. Ann Rheum Dis 2009;68:1466-9.